N.S. moving to Biosimilar drugs for Pharmacare program
HALIFAX: Beginning Feb. 4, the province has announced that Nova Scotians enrolled in Pharmacare programs will begin switching to a biosimilar version of certain biologic drugs, including some insulins and…